Compare SST & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SST | POM |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | United States | China |
| Employees | 250 | N/A |
| Industry | Diversified Commercial Services | Other Specialty Stores |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9M | 13.5M |
| IPO Year | N/A | N/A |
| Metric | SST | POM |
|---|---|---|
| Price | $2.70 | $0.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | 2.1M | ★ 18.1M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.34 | $0.06 |
| 52 Week High | $11.30 | $6.43 |
| Indicator | SST | POM |
|---|---|---|
| Relative Strength Index (RSI) | 41.99 | 36.82 |
| Support Level | $2.01 | $0.06 |
| Resistance Level | $4.84 | $0.43 |
| Average True Range (ATR) | 0.52 | 0.09 |
| MACD | -0.17 | -0.02 |
| Stochastic Oscillator | 1.94 | 10.43 |
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It operate several flagship brands across multiple consumer verticals, including shopping, travel and search, and a customer acquisition and marketing platform powered by Artificial Intelligence and machine learning. The company's segment includes Marketing and Products. It generates maximum revenue from the Marketing segment. Geographically, it operates in United States and Other countries.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.